NATALIE PRICE, APRN
Family Nurse Practitioner · LAS CRUCES, NM
Individual Active NPI 1942915137
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|
| 2024 | 378 | 118,075 | $6,573,085 | $2,717,647 | $2,157,785 |
| 2023 | 106 | 15,842 | $1,060,790 | $387,201 | $308,512 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|
| J0174 | Injection, lecanemab-irmb, 1 mg | 32,800 | $1 | $1 |
| J1306 | Injection, inclisiran, 1 mg | 12,212 | $12 | $10 |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 9,030 | $18 | $14 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 8,400 | $11 | $8 |
| J2357 | Injection, omalizumab, 5 mg | 6,750 | $38 | $30 |
| J0897 | Injection, denosumab, 1 mg | 5,460 | $25 | $20 |
| J2182 | Injection, mepolizumab, 1 mg | 3,800 | $30 | $24 |
| J3245 | Injection, tildrakizumab, 1 mg | 1,700 | $135 | $107 |
| 96372 | Injection of drug or substance under skin or into muscle | 529 | $12 | $10 |
| J0517 | Injection, benralizumab, 1 mg | 510 | $166 | $131 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 79 | $119 | $95 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 71 | $51 | $38 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | 76837 | NM |
| Family Nurse Practitioner | 363LF0000X | | 78565 | ID |
| Nurse Practitioner | 363L00000X | | 3018933 | KY |
| Nurse Practitioner | 363L00000X | | 293147 | AZ |
| Family Nurse Practitioner | 363LF0000X | | CRXN.0101059-C-NP | CO |
| Family Nurse Practitioner | 363LF0000X | | APRN11043020 | FL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.